These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7897364)

  • 41. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
    Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
    J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1.
    Twagirumugabe T; Swaibu G; Walker TD; Lindh M; Gahutu JB; Bergström T; Norder H
    BMC Infect Dis; 2017 Jan; 17(1):32. PubMed ID: 28056881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of serum and hepatic markers of hepatitis B viral infection in HBsAg-positive and HBsAg-negative chronic active hepatitis.
    Freiman J; Eckstein R; McCaughan G; Parsons C; Davies JS; Diegutis P; Burnett L; Gallagher N
    Hepatology; 1985; 5(1):50-3. PubMed ID: 3855403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of HBeAg/anti-HBe immune complexes in the reactivation of hepatitis B virus replication among anti-HBe chronic carriers.
    Castillo I; Bartolomé J; Quiroga JA; Porres JC; Carreño V
    Liver; 1990 Apr; 10(2):79-84. PubMed ID: 2352457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B E antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection.
    Villari D; Pollicino T; Spinella S; Russo F; Campo S; Rodino G; Squadrito G; Longo G; Raimondo G
    Am J Clin Pathol; 1995 Feb; 103(2):136-40. PubMed ID: 7856554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis.
    Kakumu S; Yoshioka K; Wakita T; Ishikawa T
    Int J Immunopharmacol; 1991; 13(2-3):141-6. PubMed ID: 1906436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen.
    Hojatizadeh M; Amiri MM; Mobini M; Hassanzadeh Makoui M; Ghaedi M; Ghotloo S; Peyghami K; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Viral Immunol; 2023; 36(6):378-388. PubMed ID: 37294935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon.
    Laskus T; Rakela J; Persing DH
    Dig Dis Sci; 1995 Jan; 40(1):1-7. PubMed ID: 7821093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha.
    Akriviadis EA; Xanthakis I; Navrozidou C; Papadopoulos A
    J Clin Gastroenterol; 1997 Dec; 25(4):612-8. PubMed ID: 9451674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.
    Fujiwara K; Yokosuka O; Ehata T; Chuang WL; Imazeki F; Saisho H; Omata M
    Dig Dis Sci; 1998 Feb; 43(2):368-76. PubMed ID: 9512133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection and characterization of pre-core mutants of hepatitis B virus (HBV) in chronically infected patients].
    López JL; Telenta PF; Palacios Poggio González J; Alonso AG; Lemberg A; Campos R
    Acta Gastroenterol Latinoam; 1995; 25(2):85-90. PubMed ID: 8525764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.